LT3550B - Process for the preparation of hexahydroazepines derivatives - Google Patents

Process for the preparation of hexahydroazepines derivatives Download PDF

Info

Publication number
LT3550B
LT3550B LTIP704A LTIP704A LT3550B LT 3550 B LT3550 B LT 3550B LT IP704 A LTIP704 A LT IP704A LT IP704 A LTIP704 A LT IP704A LT 3550 B LT3550 B LT 3550B
Authority
LT
Lithuania
Prior art keywords
formula
compound
group
give
hydrogen
Prior art date
Application number
LTIP704A
Other languages
English (en)
Lithuanian (lt)
Inventor
Serge Lavastre
Jean-Pierre Maignan
Raymond Paul
Martine Poncelet
Vincent Santucci
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of LTIP704A publication Critical patent/LTIP704A/xx
Publication of LT3550B publication Critical patent/LT3550B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Control Of Transmission Device (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTIP704A 1990-06-14 1993-06-23 Process for the preparation of hexahydroazepines derivatives LT3550B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR909007434A FR2663328B1 (fr) 1990-06-14 1990-06-14 Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
LTIP704A LTIP704A (en) 1995-01-31
LT3550B true LT3550B (en) 1995-11-27

Family

ID=9397608

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP704A LT3550B (en) 1990-06-14 1993-06-23 Process for the preparation of hexahydroazepines derivatives

Country Status (30)

Country Link
US (2) US5231092A (hu)
EP (1) EP0461986B1 (hu)
JP (1) JP2620422B2 (hu)
KR (1) KR100213531B1 (hu)
AT (1) ATE132861T1 (hu)
AU (1) AU647481B2 (hu)
BR (1) BR1100207A (hu)
CA (1) CA2044484C (hu)
CZ (1) CZ285696B6 (hu)
DE (1) DE69116237T2 (hu)
DK (1) DK0461986T3 (hu)
ES (1) ES2084792T3 (hu)
FI (1) FI101301B (hu)
FR (1) FR2663328B1 (hu)
GR (1) GR3019197T3 (hu)
HK (1) HK1000598A1 (hu)
HU (2) HU222490B1 (hu)
IE (1) IE74709B1 (hu)
IL (1) IL98479A (hu)
LT (1) LT3550B (hu)
LV (1) LV10433B (hu)
MX (1) MX9203360A (hu)
MY (1) MY135774A (hu)
NO (1) NO180195C (hu)
NZ (1) NZ238516A (hu)
PL (1) PL165842B1 (hu)
PT (1) PT97944B1 (hu)
RU (2) RU2133741C1 (hu)
UA (1) UA27222C2 (hu)
ZA (1) ZA914572B (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
US6005102A (en) * 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
FR2794742B1 (fr) * 1999-06-11 2005-06-03 Sanofi Synthelabo Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
FR2795724B1 (fr) * 1999-07-02 2002-12-13 Sanofi Synthelabo Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2162438A4 (en) 2007-05-30 2011-07-06 Ind Swift Lab Ltd PROCESS FOR THE PREPARATION OF IVABRADINE HYDROCHLORIDE AND CORRESPONDING POLYMORPHIDE
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2022058533A1 (en) 2020-09-17 2022-03-24 Meletios Therapeutics Compounds for treating virus infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2249659A1 (hu) 1973-11-02 1975-05-30 Clin Midy
US4709094A (en) 1986-07-10 1987-11-24 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Sigma brain receptor ligands and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2881165A (en) * 1956-06-29 1959-04-07 Nl Combinatie Chem Ind alpha-alpha-diphenyl-gamma-hexamethyleneiminobutyramide
DE1545561A1 (de) * 1965-08-23 1969-12-11 Acraf Verfahren zur Herstellung von pharmakologisch aktiven N,N-disubstituierten 1-Aryl-3-aminopropinen
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
DE3019497A1 (de) * 1980-05-22 1981-11-26 Bayer Ag, 5090 Leverkusen Aminopropiophenon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
AU4261285A (en) * 1984-06-01 1985-12-05 Tokyo Tanabe Company Limited 1-propanone derivatives
DE3508398A1 (de) * 1985-03-08 1986-11-06 Hoechst Ag, 6230 Frankfurt Fungizide mittel auf der basis von 3-(hetero)-arylpropylaminen sowie neue (hetero)-aryl-propylamine und verfahren zu ihrer herstellung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2249659A1 (hu) 1973-11-02 1975-05-30 Clin Midy
US4709094A (en) 1986-07-10 1987-11-24 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Sigma brain receptor ligands and their use

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
B. KENNETH KOE ET AL.: "(+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine binding to σ receptors in mouse brain in vivo", EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, pages 263 - 266, XP025545429, DOI: doi:10.1016/0014-2999(89)90857-1
JEREMY Z. FIELDS ET AL.: "Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol", BRAIN RESEARCH, 1987, pages 578 - 584
LARGENT BL, GUNDLACH AL, SNYDER SH: "Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine", J PHARMACOL EXP THER., 1986, pages 739 - 748
LARGENT BL, GUNDLACH AL, SNYDER SH: "Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine", PROC NATL ACAD SCI USA., 1984, pages 4983 - 4987
MARTIN WR, EADES CG, THOMPSON JA, HUPPLER RE,: "The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog", J PHARMACOL EXP THER., 1976, pages 517 - 532, XP009075978
P. SIMON ET AL.: "La farmacoterapia nella schizofrenia", pages: 49 - 66
R. L. AUGUSTINE: "Catalytic Hydrogenation", pages: 69 - 71
WEBER E, SONDERS M, QUARUM M, MCLEAN S, POU S: "1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs", PROC NATL ACAD SCI USA., 1986, pages 8784 - 8788

Also Published As

Publication number Publication date
BR1100207A (pt) 1999-10-05
UA27222C2 (uk) 2000-08-15
KR920000728A (ko) 1992-01-29
FR2663328A1 (fr) 1991-12-20
US5231092A (en) 1993-07-27
FI912899A (fi) 1991-12-15
JP2620422B2 (ja) 1997-06-11
PT97944A (pt) 1992-03-31
LV10433B (en) 1995-08-20
EP0461986A1 (fr) 1991-12-18
CA2044484A1 (en) 1991-12-15
CZ285696B6 (cs) 1999-10-13
HK1000598A1 (en) 1998-04-09
DE69116237T2 (de) 1996-07-25
DK0461986T3 (da) 1996-05-28
HU222490B1 (hu) 2003-07-28
RU2133741C1 (ru) 1999-07-27
CA2044484C (en) 1998-05-26
NO180195B (no) 1996-11-25
NO912283L (no) 1991-12-16
US5296596A (en) 1994-03-22
FI101301B1 (fi) 1998-05-29
IL98479A (en) 1995-11-27
IE74709B1 (en) 1997-07-30
RU94038042A (ru) 1996-09-10
RU2070194C1 (ru) 1996-12-10
FR2663328B1 (fr) 1994-08-05
FI912899A0 (fi) 1991-06-14
NO912283D0 (no) 1991-06-13
HU211616A9 (en) 1995-12-28
GR3019197T3 (en) 1996-06-30
PL290675A1 (en) 1992-03-23
NO180195C (no) 1997-03-05
AU7843491A (en) 1991-12-19
KR100213531B1 (ko) 1999-08-02
ZA914572B (en) 1992-03-25
HU9101983D0 (en) 1991-12-30
DE69116237D1 (de) 1996-02-22
PL165842B1 (pl) 1995-02-28
IL98479A0 (en) 1992-07-15
ATE132861T1 (de) 1996-01-15
PT97944B (pt) 1998-11-30
PT97944B1 (pt) 1999-05-31
EP0461986B1 (fr) 1996-01-10
ES2084792T3 (es) 1996-05-16
NZ238516A (en) 1993-09-27
LV10433A (lv) 1995-02-20
MY135774A (en) 2008-06-30
CZ181891A3 (en) 1994-01-19
FI101301B (fi) 1998-05-29
LTIP704A (en) 1995-01-31
HUT61736A (en) 1993-03-01
MX9203360A (es) 1992-07-01
IE911963A1 (en) 1991-12-18
JPH04321676A (ja) 1992-11-11
AU647481B2 (en) 1994-03-24

Similar Documents

Publication Publication Date Title
JP2902701B2 (ja) 新規な１，２―シクロヘキシルアミノアリールアミド類
LT3550B (en) Process for the preparation of hexahydroazepines derivatives
IL36237A (en) Substituted benzylimidazolidinones,their preparation and pharmaceutical compositions containing them
CA2004575A1 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
EA011689B1 (ru) Имидазольные соединения для лечения нейродегенеративных расстройств
KR100196985B1 (ko) 피페리딘 유도체
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
FI98811C (fi) Menetelmä immuunijärjestelmään vaikuttavien bentseenijohdannaisten valmistamiseksi
US3683085A (en) Secondaryamino pyridazines
EP0668275A1 (en) Pyrrolidinone derivatives
JP3786983B2 (ja) ピロリジノン誘導体
SK1182000A3 (en) 2-{3-[4-(2-T-BUTYL-6-TRIFLUOROMETHYLPYRIDIN-4-YL)-PIPERAZIN-ì (54) -1-YL]PROPYLMERCAPTO} PYRIMIDIN-4-OL-FUMARATE
US4626542A (en) 4-(5H-dibenzo[a,d]cyclohepten-5-yl)piperidine compounds, pharmaceutical compositions and methods
JP3786984B2 (ja) ピペラジン誘導体
JPS59130280A (ja) ７−フエニル−７−フエノキシメチル−ヘキサヒドロ−１，４−オキサゼピン、その製法及び用途
JPH0558633B2 (hu)
GB1589776A (en) Tetrabenzocycloheptenes
JPH0525044A (ja) 抗不整脈薬
JPH05194465A (ja) 鎮痛剤として有用な２−アミノ−モノ−メトキシシクロヘキシルアミド類
JPH07252220A (ja) ピロリジノン誘導体
KR20010072407A (ko) Ｎ-치환 아자비시클로헵탄 유도체, 그의 제조 및 용도

Legal Events

Date Code Title Description
PD9A Change of patent owner

Free format text: SANOFI,32-34 RUE MARBEUF, 75008 PARIS,FR,19970918

PC9A Transfer of patents

Free format text: SANOFI-SYNTHELABO, 174 AVENUE DE FRANCE, 75013 PARIS,FR, 0000515,

PD9A Change of patent owner

Owner name: SANOFI-AVENTIS, FR

Effective date: 20041213

MM9A Lapsed patents

Effective date: 20090623